NL-OMON25605招募中不适用
Association of Graves' disease and thymic hyperplasia.
Erasmus Medical Center, Rotterdam, The Netherlands0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Graves' disease;
- •2. 18-40 years of age.
排除标准
- •1. Use of corticosteroids last three months;
- •2. Infections during last three months;
研究者
相似试验
已完成
不适用
Association of Graves' disease and thymic hyperplasia and the role of TSH receptor antibodies in T cell developmentthymus hyperplasie10043739HyperthyroidismNL-OMON35294Erasmus MC, Universitair Medisch Centrum Rotterdam30
已完成
不适用
Change of Gut Microbiome in the Treatment of Graves' DiseaseGraves' DiseaseNCT04383795Seoul St. Mary's Hospital29
已完成
不适用
The Role of the Thymus in Myasthenia GravisMyasthenia GravisThymomaNCT01102192Charite University, Berlin, Germany20
已完成
不适用
HIFU vs RAI in the Relapsed Graves' DiseaseGraves DiseaseNCT03013257The University of Hong Kong240
招募中
3 期
A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' OrbitopathyGraves' OrbitopathyNCT04776993University of Pisa52
